Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-19

Clinical Trial Update: Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines [Phase 3]

View source ↗

Summary

Phase 3 trial investigating elective level Ib irradiation in nasopharyngeal carcinoma following international guidelines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN